BioRem Retained Earnings vs Current Deferred Revenue Analysis

BRM Stock

CAD 1.90 0.05 2.56%

BioRem financial indicator trend analysis is way more than just evaluating BioRem Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioRem Inc is a good investment. Please check the relationship between BioRem Retained Earnings and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Retained Earnings vs Current Deferred Revenue

Retained Earnings vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioRem Inc Retained Earnings account and Current Deferred Revenue. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between BioRem's Retained Earnings and Current Deferred Revenue is 0.47. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of BioRem Inc, assuming nothing else is changed. The correlation between historical values of BioRem's Retained Earnings and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of BioRem Inc are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Retained Earnings i.e., BioRem's Retained Earnings and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.47

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from BioRem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioRem Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

At this time, BioRem's Tax Provision is fairly stable compared to the past year. Issuance Of Capital Stock is likely to climb to about 72.5 K in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.06 in 2024.

	2021	2022	2023	2024 (projected)
Total Revenue	24.5M	28.9M	25.2M	18.5M
Depreciation And Amortization	343.6K	350.6K	382.7K	281.4K

Total Revenue Depreciation And Amortization

BioRem fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Accounts Payable	Current Deferred Revenue	Good Will	Intangible Assets	Non Currrent Assets Other
Total Assets		-0.06	0.67	0.67	0.77	0.58	-0.5	0.52	0.7	0.87	0.7	0.85	0.48	0.18	0.51	0.26	-0.49	0.61	0.99	-0.47	0.06	0.74	0.67	-0.23	-0.59	0.85
Short Long Term Debt Total	-0.06		0.26	0.55	-0.63	0.38	0.76	0.14	-0.36	0.01	-0.36	0.07	-0.42	0.81	0.04	0.28	0.25	0.7	-0.08	0.54	-0.7	0.35	0.23	-0.17	-0.02	0.05
Other Current Liab	0.67	0.26		0.56	0.33	0.52	-0.18	0.67	0.46	0.75	0.46	0.53	-0.01	0.58	0.29	-0.03	-0.41	0.64	0.61	-0.35	-0.44	0.46	0.35	-0.02	-0.04	0.67
Total Current Liabilities	0.67	0.55	0.56		0.08	0.54	0.18	0.22	0.13	0.49	0.13	0.77	0.17	0.57	0.34	0.38	-0.08	0.95	0.69	0.18	-0.25	0.91	0.67	-0.17	-0.56	0.44
Total Stockholder Equity	0.77	-0.63	0.33	0.08		0.25	-0.87	0.35	0.82	0.69	0.82	0.5	0.63	-0.39	0.37	0.06	-0.52	-0.03	0.76	-0.65	0.47	0.24	0.33	-0.13	-0.44	0.68
Property Plant And Equipment Net	0.58	0.38	0.52	0.54	0.25		0.09	0.64	0.29	0.64	0.27	0.43	-0.11	0.59	0.42	0.74	-0.17	0.6	0.51	-0.14	-0.36	0.52	0.82	-0.75	-0.25	0.72
Net Debt	-0.5	0.76	-0.18	0.18	-0.87	0.09		-0.05	-0.86	-0.45	-0.86	-0.15	-0.67	0.56	-0.37	0.27	0.39	0.3	-0.5	0.59	-0.63	0.1	0.03	-0.26	0.28	-0.35
Retained Earnings	0.52	0.14	0.67	0.22	0.35	0.64	-0.05		0.27	0.62	0.25	0.44	-0.14	0.47	0.09	0.22	-0.68	0.38	0.45	-0.57	-0.64	0.32	0.47	-0.53	0.21	0.77
Cash	0.7	-0.36	0.46	0.13	0.82	0.29	-0.86	0.27		0.69	1.0	0.26	0.66	-0.2	0.59	-0.03	-0.43	0.08	0.67	-0.47	0.38	0.13	0.26	0.04	-0.46	0.64
Non Current Assets Total	0.87	0.01	0.75	0.49	0.69	0.64	-0.45	0.62	0.69		0.69	0.58	0.25	0.34	0.55	0.22	-0.35	0.51	0.79	-0.46	-0.09	0.51	0.47	-0.2	-0.32	0.91
Cash And Short Term Investments	0.7	-0.36	0.46	0.13	0.82	0.27	-0.86	0.25	1.0	0.69		0.26	0.66	-0.21	0.58	-0.06	-0.42	0.08	0.67	-0.47	0.38	0.13	0.23	0.08	-0.46	0.62
Net Receivables	0.85	0.07	0.53	0.77	0.5	0.43	-0.15	0.44	0.26	0.58	0.26		0.34	0.23	0.18	0.24	-0.44	0.71	0.88	-0.32	-0.09	0.89	0.69	-0.24	-0.52	0.61
Common Stock Shares Outstanding	0.48	-0.42	-0.01	0.17	0.63	-0.11	-0.67	-0.14	0.66	0.25	0.66	0.34		-0.55	0.2	-0.14	-0.38	-0.02	0.53	-0.09	0.61	0.22	0.18	0.15	-0.67	0.27
Non Current Liabilities Total	0.18	0.81	0.58	0.57	-0.39	0.59	0.56	0.47	-0.2	0.34	-0.21	0.23	-0.55		0.22	0.26	0.1	0.76	0.12	0.07	-0.8	0.48	0.35	-0.24	0.2	0.3
Inventory	0.51	0.04	0.29	0.34	0.37	0.42	-0.37	0.09	0.59	0.55	0.58	0.18	0.2	0.22		0.27	-0.06	0.35	0.48	-0.27	0.17	0.38	0.41	-0.1	-0.43	0.45
Other Current Assets	0.26	0.28	-0.03	0.38	0.06	0.74	0.27	0.22	-0.03	0.22	-0.06	0.24	-0.14	0.26	0.27		0.12	0.33	0.24	0.18	-0.1	0.39	0.7	-0.81	-0.41	0.37
Other Stockholder Equity	-0.49	0.25	-0.41	-0.08	-0.52	-0.17	0.39	-0.68	-0.43	-0.35	-0.42	-0.44	-0.38	0.1	-0.06	0.12		-0.12	-0.5	0.6	0.23	-0.2	-0.34	0.21	0.02	-0.54
Total Liab	0.61	0.7	0.64	0.95	-0.03	0.6	0.3	0.38	0.08	0.51	0.08	0.71	-0.02	0.76	0.35	0.33	-0.12		0.61	0.08	-0.49	0.86	0.64	-0.2	-0.38	0.48
Total Current Assets	0.99	-0.08	0.61	0.69	0.76	0.51	-0.5	0.45	0.67	0.79	0.67	0.88	0.53	0.12	0.48	0.24	-0.5	0.61		-0.44	0.1	0.77	0.67	-0.19	-0.64	0.77
Short Term Debt	-0.47	0.54	-0.35	0.18	-0.65	-0.14	0.59	-0.57	-0.47	-0.46	-0.47	-0.32	-0.09	0.07	-0.27	0.18	0.6	0.08	-0.44		0.0	-0.09	-0.19	0.11	-0.18	-0.48
Common Stock	0.06	-0.7	-0.44	-0.25	0.47	-0.36	-0.63	-0.64	0.38	-0.09	0.38	-0.09	0.61	-0.8	0.17	-0.1	0.23	-0.49	0.1	0.0		-0.18	-0.15	0.27	-0.5	-0.19
Accounts Payable	0.74	0.35	0.46	0.91	0.24	0.52	0.1	0.32	0.13	0.51	0.13	0.89	0.22	0.48	0.38	0.39	-0.2	0.86	0.77	-0.09	-0.18		0.75	-0.31	-0.56	0.53
Current Deferred Revenue	0.67	0.23	0.35	0.67	0.33	0.82	0.03	0.47	0.26	0.47	0.23	0.69	0.18	0.35	0.41	0.7	-0.34	0.64	0.67	-0.19	-0.15	0.75		-0.73	-0.54	0.64
Good Will	-0.23	-0.17	-0.02	-0.17	-0.13	-0.75	-0.26	-0.53	0.04	-0.2	0.08	-0.24	0.15	-0.24	-0.1	-0.81	0.21	-0.2	-0.19	0.11	0.27	-0.31	-0.73		0.15	-0.49
Intangible Assets	-0.59	-0.02	-0.04	-0.56	-0.44	-0.25	0.28	0.21	-0.46	-0.32	-0.46	-0.52	-0.67	0.2	-0.43	-0.41	0.02	-0.38	-0.64	-0.18	-0.5	-0.56	-0.54	0.15		-0.37
Non Currrent Assets Other	0.85	0.05	0.67	0.44	0.68	0.72	-0.35	0.77	0.64	0.91	0.62	0.61	0.27	0.3	0.45	0.37	-0.54	0.48	0.77	-0.48	-0.19	0.53	0.64	-0.49	-0.37

Click cells to compare fundamentals

BioRem Account Relationship Matchups

BioRem fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	17.6M	22.0M	19.2M	20.7M	24.1M	15.1M
Other Current Liab	1.9M	3.3M	3.4M	4.2M	2.7M	2.0M
Total Current Liabilities	5.9M	7.8M	13.2M	12.9M	13.9M	7.9M
Total Stockholder Equity	11.7M	13.5M	2.0M	4.5M	6.7M	6.0M
Property Plant And Equipment Net	372.9K	1.4M	1.1M	1.0M	2.0M	2.1M
Net Debt	(6.4M)	(8.0M)	1.2M	971.1K	1.9M	2.0M
Retained Earnings	(9.1M)	(7.0M)	(5.7M)	(4.1M)	(1.9M)	(2.0M)
Cash	6.5M	8.9M	4.5M	3.8M	2.3M	3.1M
Non Current Assets Total	3.1M	3.7M	3.0M	3.0M	3.5M	1.9M
Cash And Short Term Investments	6.5M	8.9M	4.5M	3.8M	2.3M	2.7M
Net Receivables	5.7M	7.6M	10.1M	12.2M	15.1M	7.8M
Common Stock Shares Outstanding	38.7M	39.5M	37.4M	17.6M	17.1M	22.9M
Liabilities And Stockholders Equity	17.6M	22.0M	19.2M	20.7M	24.1M	15.1M
Inventory	1.3M	944.8K	901.7K	888.0K	901.1K	764.8K
Other Current Assets	1.0M	857.3K	658.9K	870.6K	2.3M	2.4M
Other Stockholder Equity	2.2M	2.2M	2.2M	2.3M	2.4M	2.3M
Total Liab	5.9M	8.4M	17.2M	16.2M	17.4M	9.0M
Total Current Assets	14.5M	18.3M	16.2M	17.8M	20.6M	12.4M
Accounts Payable	2.4M	1.8M	5.1M	4.7M	6.1M	3.4M
Accumulated Other Comprehensive Income	1.4M	1.1M	597.3K	1.4M	1.3M	653.8K
Current Deferred Revenue	1.6M	2.5M	3.0M	2.6M	4.3M	4.5M
Net Tangible Assets	12.9M	11.7M	13.5M	2.0M	2.3M	2.1M
Property Plant Equipment	262.5K	372.9K	1.4M	1.1M	1.3M	1.4M
Net Invested Capital	11.7M	13.5M	7.0M	8.8M	9.7M	8.1M
Net Working Capital	8.6M	10.5M	2.9M	4.9M	6.7M	5.8M

Pair Trading with BioRem

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioRem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioRem will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to BioRem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioRem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioRem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioRem Inc to buy it.

The correlation of BioRem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioRem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioRem Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for BioRem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for BioRem Stock analysis

When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.

	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments

Please note, there is a significant difference between BioRem's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioRem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioRem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioRem Retained Earnings vs Current Deferred Revenue Analysis

Retained Earnings vs Current Deferred Revenue

Retained Earnings vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Retained Earnings

Current Deferred Revenue

BioRem fundamental ratios Correlations

BioRem Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BioRem fundamental ratios Accounts

Pair Trading with BioRem

Complementary Tools for BioRem Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Total Assets
Total Liab	+ 0.95	Total Current Liabilities
Accounts Payable	+ 0.91	Total Current Liabilities
Non Currrent Assets Other	+ 0.91	Non Current Assets Total
Accounts Payable	+ 0.89	Net Receivables

Net Debt	- 0.87	Total Stockholder Equity
Cash And Short Term Investments	- 0.86	Net Debt
Cash	- 0.86	Net Debt
Good Will	- 0.81	Other Current Assets
Common Stock	- 0.8	Non Current Liabilities Total
Good Will	- 0.75	Property Plant And Equipment Net